Camlin Fine Sciences Receives ₹5.47 Crore Income Tax Demand Notice for AY 2023-24

1 min read     Updated on 11 Apr 2026, 12:19 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited has received an income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24 related to transfer pricing adjustments on transactions with Associated Enterprises. The company disclosed this to stock exchanges under SEBI regulations and stated it plans to file an appeal against the order. The company has clarified that there is no immediate impact on its financial or operational activities due to this development.

powered bylight_fuzz_icon
37392579

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has received a significant income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24, the company disclosed to stock exchanges on April 10, 2026. The notice was issued under section 156 of the Income-Tax Act, 1961, following an Assessment Order from the Income Tax Department's Assessment Unit.

Details of the Tax Demand

The demand notice requires the company to deposit the specified amount within 30 days of service. The primary reason for this substantial demand relates to transfer pricing adjustments, specifically concerning Arm's Length Price adjustments for international and domestic transactions entered into by the company with its Associated Enterprises.

Parameter Details
Issuing Authority Assessment Unit, Income Tax Department
Demand Amount ₹5,46,98,560
Assessment Year 2023-24
Legal Provision Section 156 of Income-Tax Act, 1961
Payment Timeline 30 days from service date
Receipt Date April 10, 2026

Nature of Assessment

The Assessment Order was issued under section 143(3) of the Income-Tax Act, 1961. The demand primarily stems from adjustments made to the Arm's Length Price regarding the value of transactions between Camlin Fine Sciences and its Associated Enterprises. This indicates that the tax authorities have questioned the pricing of inter-company transactions and made upward adjustments, resulting in additional tax liability.

Company's Response and Impact

Camlin Fine Sciences has stated that there is no immediate impact on the company's financial, operational, or other activities due to this order. The company has examined the assessment order and is currently in the process of filing an appeal against it. This suggests that the company disagrees with the tax authorities' assessment and intends to challenge the demand through the appellate process.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure was made simultaneously to both BSE Limited and the National Stock Exchange of India Limited, ensuring transparency with all stakeholders regarding this material development.

The disclosure was signed by Rahul Sawale, Company Secretary and VP Legal, indicating the seriousness with which the company is treating this matter and its commitment to proper corporate governance practices.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.32%+1.99%-24.44%-47.39%-34.41%-19.76%

How might this transfer pricing dispute affect Camlin Fine Sciences' future international expansion and subsidiary structuring strategies?

What potential impact could a prolonged appellate process have on the company's cash flow and working capital management?

Will this tax demand prompt increased regulatory scrutiny of transfer pricing practices across the broader chemical and fine sciences industry?

Camlin Fine Sciences Promoter Pledges Additional 6.50 Lakh Shares for Margin Requirements

2 min read     Updated on 10 Apr 2026, 01:33 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged an additional 6.50 lakh equity shares to Ashika Credit Capital Limited as margin for financial assistance shortfall. The pledge, created on March 30, 2026, brings the total encumbered shares to 1.53 crore (7.96% of share capital), valued at ₹6.30 crore. The disclosure complies with SEBI SAST Regulations and confirms the pledge is for the listed company's benefit rather than personal use.

powered bylight_fuzz_icon
37351647

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged additional equity shares as margin for financial assistance, according to a regulatory disclosure filed on April 9, 2026. The pledge was created on March 30, 2026, in favor of Ashika Credit Capital Limited to address shortfall in security cover requirements.

Share Pledge Details

The latest encumbrance involves 6.50 lakh equity shares, representing 0.34% of the company's total share capital. This pledge was created as additional margin to cover shortfall in security cover with respect to financial assistance obtained by the target company.

Parameter: Details
Shares Pledged: 6.50 lakh
Percentage of Share Capital: 0.34%
Date of Pledge: March 30, 2026
Beneficiary: Ashika Credit Capital Limited
Type of Encumbrance: Pledge
Share Value on Event Date: ₹6.30 crore

Promoter Shareholding Position

Following this transaction, Dandekar's total encumbered shareholding has increased significantly. The promoter maintains a substantial stake in the company while using a major portion as collateral for financial arrangements.

Shareholding Details: Current Position
Total Promoter Holding: 1.98 crore shares (10.30%)
Previously Encumbered: 1.47 crore shares (7.62%)
Additional Pledge: 6.50 lakh shares (0.34%)
Total Encumbered Shares: 1.53 crore shares (7.96%)
Encumbered as % of Promoter Holding: 77.36%

Regulatory Compliance Framework

The disclosure was made in compliance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that while the encumbered shares represent more than 50% of the promoter's shareholding, they constitute less than 20% of the company's total share capital.

Compliance Parameter: Status
Encumbered Share ≥ 50% of Promoter Holding: YES
Encumbered Share ≥ 20% of Total Share Capital: NO
Stock Exchanges Notified: BSE Limited, NSE
Reporting Date: April 9, 2026

Ashika Credit Capital Limited, the entity in whose favor the shares have been pledged, operates as a non-banking financial company (NBFC). The pledge arrangement does not involve any debt instruments such as debentures, commercial paper, or certificates of deposit.

Purpose and Utilization

The encumbrance serves as additional margin pledge for covering shortfall in security cover related to financial assistance obtained by Camlin Fine Sciences. This indicates the pledge is being utilized for the benefit of the listed company rather than for personal use by the promoter. The arrangement helps ensure adequate collateral coverage for the company's financial assistance requirements, demonstrating the promoter's commitment to supporting the company's operational needs.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.32%+1.99%-24.44%-47.39%-34.41%-19.76%

What specific financial challenges or expansion plans might have triggered Camlin Fine Sciences' need for additional security cover?

How might the high promoter pledge ratio of 77.36% impact investor confidence and the company's ability to raise future equity capital?

Will Camlin Fine Sciences need to explore alternative financing arrangements if the promoter's remaining unpledged shares become insufficient for future collateral requirements?

More News on Camlin Fine Sciences

1 Year Returns:-34.41%